Improving the adaptive capacity of the brain is a basic factor in the prevention of cerebrovascular diseases
DOI: https://dx.doi.org/10.18565/therapy.2020.3.33-38
Sokolova L.P.
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow
It is known that chronic cerebral ischemia (CCI) is in a lot of ways caused by cerebral blood flow autoregulation disorders
The purpose of the study is to study the influence of neurometabolic drugs (using Cerebrolysin as an example) on adaptability capacities, and on increase brain resistance to stress in CHCI patients.
Material and methods. In 25 CCI patients the background level of constant cerebral potentials was studied (SCP is an indicator of super slow brain activity that correlates with neurometabolism activity), as well as its changes during functional afferent tests before treatment and after the course of treatment with Cerebrolysin medicine.
Results. The course of neurometabolic therapy (Cerebrolysin) activated background cerebral metabolism (SCP), improved stress resistance indexes (a significant increase in the number of patients with an adequate response to hyperventilation and a quick language arts test). Also after completion of treatment, there was a significant increase in the number of patients with complete SCP restoration in the posthyperventilation period.
Conclusion. The course of neurometabolic therapy improves adaptation to physical and cognitive (emotional) stress, activates the background metabolism of the brain, increases its stress tolerance, optimizes changes in brain metabolism under stress, and improves recovery of homeostasis. The peculiarities of brain metabolism reactivity by SCP should be taken into account when prescribing complex medicamental therapy: with a predominance of decompensated adaptation to emotional stress, the emphasis in therapy should be placed on psychocorrection, with a prevalence of maladaptation to physical stress, it should be placed on physical methods of exposure and muscle relaxation.
Literature
- Вейн А.М. Семь лекций на Россолимо. М.: Нейромедиа, 2004; 220 с. [Veyn A.M. Seven lectures on Rossolimo Str. M.: Neyromediya. 2004; 220 p. (In Russ.)].
- Cоколова Л.П. Адаптация к стрессу – основополагающий фактор жизнеспособности и когнитивной активности. Клиническая геронтология. 2011; 5–6: 16–20. [Sokolova L.P. Adaptation to stress – the basic factor of vitality and cognitive activity. Klinicheskaya gerontologiya. 2011; 5–6: 16–20 (In Russ.)].
- Селье Г. Очерки об адаптационном синдроме. М.: Медгиз. 1960; 255 с. [Selie G. Essays on adaptation syndrome. M.: Medgiz. 1960; 255 p. (In Russ.)].
- Соколова Л.П. Особенности нейрометаболизма и перфузии головного мозга с позиции патогенетических механизмов формирования додементных когнитивных расстройств различного генеза. Автореф. дис. М., 2012; 44 с. [Sokolova L.P. Features of brain neurometabolism and perfusion from a position of pathogenetic mechanisms of formation of different origin predemented cognitive disorders. Doctoral dissertation abstract. М. 2012; 44 p. (In Russ.)].
- Sokoloff L. Energetics of functional activation in neural tissues. Neurochem. Res. 1999; 24(2): 321–29.
- Соколова Л.П. Функциональная активность мозга и нейрометаболизм при когнитивных нарушениях различного генеза. Фундаментальные исследования. 2011; 11: 131–136. [Sokolova L.P. Functional activity and metabolism of brain in cases of cognitive impairments of various origin. Fundamental'nye issledovaniya. 2011; 11: 131–136 (In Russ.)].
- Федин А.И. Амбулаторная неврология. Избранные лекции для врачей первичного звена здравоохранения. М.: ГЭОТАР-Медиа, 2019; 464 с. [Fedin A.I. Outpatient neurology. Selected lectures for primary-care physicians. M.: GEOTAR-Media. 2019; 464 p. (In Russ.)].
- Фокин В.Ф., Пономарева Н.В. Интенсивность церебрального энергетического обмена: возможности его оценки электрофизиологическим методом. Вестник РАМН. 2001; 8: 38–43. [Fokin V.F., Ponomareva N.V. Cerebral energy metabolism: electrophysiological assessment options. Vestnik RAMN. 2001; 8: 38–43 (In Russ.)].
- Фокин В.Ф., Пономарева Н.В. Энергетическая физиология мозга. М.: Антидор. 2003; 288 с. [Fokin V.F., Ponomareva N.V. Energy physiology of brain. M.: Antidor. 2003; 288 p. (In Russ.)].
- Хомская Е.Д. Нейропсихологическая диагностика. Ч. 1. М.: Институт общегуманитарных исследований, 2007; 64 с. [Khomskaya E.D. Neuropsychological diagnostics. Part 1. M.: Institute of General Humanitarian Studies. 2007; 64 p. (In Russ.)].
- Гордеева И.Е., Ансаров Х.Ш., Соколова В.Ю. Эффективность Церебролизина при хронической ишемии головного мозга. Эффективная фармакотерапия. 2018; 1: 6–9. [Gordeyeva I.Ye., Ansarov Kh.Sh., Sokolova V.Yu. Cerebrolysin efficacy in patients with chronic cerebral ischemia. Effektivnaya farmakoterapiya. 2018; 1: 6–9 (In Russ.)].
- Чуканова Е.И. Сравнительный анализ эффективности Церебролизина при лечении пациентов с хронической ишемией мозга. Фармакоэкономические аспекты. Трудный пациент. 2011; 9(1): 32–37. [Comparative analysis of Cerebrolysin efficacy in patients with chronic cerebral ischemia. Pharmacoeconomic aspects. Trudny patsient. 2011; 9(1): 32–37 (In Russ.)].
About the Autors
Lyubov P. Sokolova, MD, professor of the Department of neurology of the faculty of continuing professional education of N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 109125, Moscow, 11–13 Vasiltsovsky stan Str. Tel.: +7 (926) 363-22-50. E-mail: lsocolova@yandex.ru
Similar Articles